INSERM U965, Hôpital Lariboisière-Saint Louis, Paris, France.
Cell Adh Migr. 2012 Nov-Dec;6(6):547-53. doi: 10.4161/cam.23332. Epub 2012 Nov 1.
Vascular endothelial growth factor A (VEGF-A) is well known for its key roles in blood vessel growth. Although most studies on VEGF and VEGF receptors have been focused on their functions in angiogenesis and in endothelial cells, the role of VEGF in cancer biology appears as an emerging area of importance. In this context, the presence of VEGF receptors in tumor cells strongly suggests that VEGF-A also promotes a wide range of functions, both in vitro and in vivo, all autocrine functions on tumor cells, including adhesion, survival, migration and invasion. Ultimately, refining our knowledge of VEGF signaling pathways in tumor cells should help us to understand why the current used treatments targeting the VEGF pathway in cancer are not universally effective in inhibiting metastasis tumors, and it should also provide new avenues for future therapies.
血管内皮生长因子 A(VEGF-A)在血管生长中起着关键作用,这是众所周知的。尽管大多数关于 VEGF 和 VEGF 受体的研究都集中在它们在血管生成和内皮细胞中的功能上,但 VEGF 在癌症生物学中的作用似乎是一个新兴的重要领域。在这种情况下,肿瘤细胞中存在 VEGF 受体强烈表明 VEGF-A 也促进了广泛的功能,无论是在体外还是体内,所有肿瘤细胞的自分泌功能,包括粘附、存活、迁移和侵袭。最终,深入了解肿瘤细胞中 VEGF 信号通路应该有助于我们理解为什么目前用于癌症中 VEGF 通路的治疗方法并非普遍有效抑制转移肿瘤,并且还应该为未来的治疗提供新的途径。